EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Human iPSC ‐derived endothelial cells promote CNS remyelination via BDNF and mTORC1 pathway

Dan Ma iD, Huiyuan Zhang, Le Yin, Hao Xu, Lida Wu, Rahul Shaji, Fatema Rezai, Ayesha Mulla, Sukhteerath Kaur, Shengjiang Tan, Boris Kysela, Yilong Wang und 3 weitere

Glia · 2024-01 · 72 (1) · 133-155

DOI: 10.1002/glia.24466 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Glia, online erschienen am 07.09.2023. Verfasst von Dan Ma und 14 weiteren Autor:innen. Beteiligte Einrichtung: Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute and Department of Clinical Neurosciences, University of Cambridge, Cambridge, U…. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Remyelination, Demyelinating Diseases. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Aston University, Royal Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Damage of myelin is a component of many diseases in the central nervous system (CNS). The activation and maturation of the quiescent oligodendrocyte progenitor cells (OPCs) are the crucial cellular processes for CNS remyelination, which is influenced by neuroinflammation in the lesion microenvironment. Endothelial cells derived from human induced pluripotent stem cells (hiPSC‐ECs) have shown promise in restoring function in various preclinical animal models. Here we ask whether and whether transplantation of hiPSC‐ECs could benefit remyelination in a mouse model of CNS demyelination. Our results show that in vitro , hiPSC‐ECs increase OPC proliferation, migration and differentiation via secreted soluble factors including brain‐derived neurotrophic factor (BDNF). hiPSC‐ECs also promote the survival of oligodendrocyte lineage cells in vitro and in vivo . Transplantation of hiPSC‐ECs into a toxin‐induced demyelination lesion in mouse corpus callosum (CC) leads to increased density of oligodendrocyte lineage cells and level of myelin in demyelinated area, correlated with a decreased neuroinflammation and an increased proportion of pro‐regenerative M2 phenotype in microglia/macrophages. The hiPSC‐EC‐exposed oligodendrocyte lineage cells showed significant increase in the level of phosphorylated S6 ribosomal protein (pS6) both in vitro and in vivo , indicating an involvement of mTORC1 pathway. These results suggest that hiPSC‐ECs may benefit myelin protection and regeneration which providing a potential source of cell therapy for a wide range of diseases and injuries associated with myelin damage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Induced Pluripotent Stem CellsRemyelinationDemyelinating DiseasesHumansMiceAnimalsBrain-Derived Neurotrophic FactorEndothelial CellsNeuroinflammatory DiseasesMyelin SheathCentral Nervous SystemOligodendrogliaCell DifferentiationMice, Inbred C57BL

Stichwörter der Autor:innen

BDNFendothelial celliPSCmTORC1neuroinflammationoligodendrocyteremyelination

Substanzen

Brain-Derived Neurotrophic Factor

Autor:innen und Institutionen

  • Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute and Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
  • Translational Medicine Research Group (TMRG), Aston Medical School, Aston University, Birmingham, UK.
  • Molecular Pharmacology Laboratory, Institute of Molecular Medicine, Peking University, Beijing, China.
  • ALLIFE Medical Science and Technology Co. Ltd, Beijing, China.
  • Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK.
  • Department of Neurology, Tiantan Hospital Capital Medical University, National Center and National Clinical Research Center for Neurological Diseases, Advanced Innovation Center for Human Brain Protection, Chinese Insti…

ORCID-Profile: Dan Ma

Förderung

  • Aston University
  • Royal Society

Zitieren

APA

Ma, D., Zhang, H., Yin, L., Xu, H., Wu, L., Shaji, R., Rezai, F., Mulla, A., Kaur, S., Tan, S., Kysela, B., Wang, Y., Chen, Z., Zhao, C., & Gu, Y. (2024). Human iPSC ‐derived endothelial cells promote CNS remyelination via BDNF and mTORC1 pathway. Glia, 72(1), 133-155. https://doi.org/10.1002/glia.24466

Vancouver

Ma D, Zhang H, Yin L, Xu H, Wu L, Shaji R, et al. Human iPSC ‐derived endothelial cells promote CNS remyelination via BDNF and mTORC1 pathway. Glia. 2024;72(1):133-155. doi:10.1002/glia.24466

BibTeX
@article{Ma2024,
  author = {Ma, Dan and Zhang, Huiyuan and Yin, Le and Xu, Hao and Wu, Lida and Shaji, Rahul and Rezai, Fatema and Mulla, Ayesha and Kaur, Sukhteerath and Tan, Shengjiang and Kysela, Boris and Wang, Yilong and Chen, Zhiguo and Zhao, Chao and Gu, Yuchun},
  title = {Human iPSC ‐derived endothelial cells promote CNS remyelination via BDNF and mTORC1 pathway},
  journal = {Glia},
  year = {2024},
  volume = {72},
  number = {1},
  pages = {133--155},
  doi = {10.1002/glia.24466}
}
Kostenlos starten →